SWINOL

This brand name is authorized in Nigeria.

Active ingredients

The drug SWINOL contains one active pharmaceutical ingredient (API):

1	Flunitrazepam UNII 620X0222FQ - FLUNITRAZEPAM
	Flunitrazepam is a member of the benzodiazepine group of drugs and is closely related to nitrazepam, flurazepam and clonazepam. It has marked sedative and hypnotic properties with a rapid onset of action and is used in severe cases of insomnia.
	Read more about Flunitrazepam

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-7436	Tablet	SWINOL 1MG TABLETS TAB 1 mg 3x10	SWINOL 1MG TABLETS Flunitrazepam Flunitrazepam 1mg Avicel Ph 101 30.32mg Lactose Powder 30mg Kollidon 90f 5mg Fd&C blue 0.68mg Hpmc 10mg Croscamellose Sodium 5mg Magnesium stearate 1 A4-7436 Drugs Nigerian Products 3x10 POM 1 07/03/2023 SWISS PHARMA NIGERIA LIMITED, , DOPEMU ROAD, IKEJA LAGOS 17745276 swipha@swiphanigeria.com Swiss Pharma Nigeria Ltd, P.o.box 463 ikeja lagos, Nigeria	31/08/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05CD03	Flunitrazepam	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-7436